Cargando…
Inhibition of the precursor and mature forms of HIV-1 protease as a tool for drug evaluation
HIV-1 protease (PR) is a homodimeric enzyme that is autocatalytically cleaved from the Gag-Pol precursor. Known PR inhibitors bind the mature enzyme several orders of magnitude more strongly than the PR precursor. Inhibition of PR at the precursor level, however, may stop the process at its rate-lim...
Autores principales: | Humpolíčková, Jana, Weber, Jan, Starková, Jana, Mašínová, Eva, Günterová, Jana, Flaisigová, Iva, Konvalinka, Jan, Majerová, Taťána |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041310/ https://www.ncbi.nlm.nih.gov/pubmed/29992979 http://dx.doi.org/10.1038/s41598-018-28638-w |
Ejemplares similares
-
Viral proteases as therapeutic targets
por: Majerová, Taťána, et al.
Publicado: (2022) -
Precursors of Viral Proteases as Distinct Drug Targets
por: Majerová, Taťána, et al.
Publicado: (2021) -
Current and Novel Inhibitors of HIV Protease
por: Pokorná, Jana, et al.
Publicado: (2009) -
HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
por: Fun, Axel, et al.
Publicado: (2011) -
Human DNA-Damage-Inducible 2 Protein Is Structurally and Functionally Distinct from Its Yeast Ortholog
por: Sivá, Monika, et al.
Publicado: (2016)